Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179946 · ClinicalTrials.gov registry record
HLA Matching - Unrelated Umbilical Cord Blood Transplantation
A clinical trial of Hematologic Diseases, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT00179946: Completed study of Hematologic Diseases, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
NCT00179946 is a study of Hematologic Diseases that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 30 participants, below the 2,236-participant average among 17 other Hematologic Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00179946, a study of Hematologic Diseases, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this protocol is to clarify the role of HLA matching in unrelated umbilical cord blood (UCB) transplantation and to identify the level of HLA matching required assuring successful outcome of unrelated UCB transplantation.
Conditions Studied
Interventions
- PROCEDURE HLA typing
Study Locations (1)
Illinois
- Ann & Robert H Lurie Children's Hospital of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2003-06 |
| Est. Completion | 2006-04 |
What the finished NCT00179946 record still lists
NCT00179946 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 2,236-participant average among 17 other Hematologic Diseases trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Hematologic Diseases appearing as the primary indexed condition, and to 1 intervention - of which HLA typing is the first listed.
NCT00179946 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00179946 about?
NCT00179946 is a clinical study titled "HLA Matching - Unrelated Umbilical Cord Blood Transplantation". The aim of this protocol is to clarify the role of HLA matching in unrelated umbilical cord blood (UCB) transplantation and to identify the level of HLA matching required assuring successful outcome of unrelated UCB transplantation.
What is the current status of trial NCT00179946?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2003-06. Estimated completion is 2006-04.
What conditions does trial NCT00179946 study?
This clinical trial studies the following conditions: Hematologic Diseases.
What interventions are being tested in trial NCT00179946?
The interventions under investigation include: HLA typing (PROCEDURE).
Who is sponsoring clinical trial NCT00179946?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00179946 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematologic Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00179946's enrollment target sits among peer trials
30 12th of 17 higher than 5 of 17 other Hematologic Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hematologic Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback
RECRUITING · Phase 1
-
The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research
RECRUITING
-
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
RECRUITING · NA
-
HEME Home Transfusion Program
RECRUITING · NA
-
A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
RECRUITING · Phase 1
-
Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia